Project cooperation
A novel exosome-based DNA delivery system to eliminate drug-resistant cancer stem cells in GBM. Scalable manufacturing toward to IND.
- Execution
- Financing
Progenicyte Japan is a next-generation biotechnology company redefining the future of healthcare. Our innovations span cutting-edge exosome-based diagnostics and drug delivery systems, non-cell-based regenerative medicine, as well as intelligent wearable or handheld medical devices. We will transform people’s dreams into life-changing realities by a bold vision and proprietary technologies.
Business Domain / 分野
Business Type / 業種
Disease Area / 疾患領域
Modalities / モダリティ
Technologies / 技術
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術
Project cooperation
A novel exosome-based DNA delivery system to eliminate drug-resistant cancer stem cells in GBM. Scalable manufacturing toward to IND.